USC/Norris Can Ctr; IDS Pharm — Los Angeles, California

USC/Norris Can Ctr; IDS Pharm is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

USC/Norris Can Ctr; IDS Pharm has participated in 1 clinical trials.

Therapeutic areas: Lymphocytic Leukemia, Chronic.

Sponsors: Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USC/Norris Can Ctr; IDS Pharm?

USC/Norris Can Ctr; IDS Pharm has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USC/Norris Can Ctr; IDS Pharm conducted?

USC/Norris Can Ctr; IDS Pharm has 1 clinical trials on record. Their work covers Lymphocytic Leukemia, Chronic.

Is USC/Norris Can Ctr; IDS Pharm accredited by Crixeo Health?

USC/Norris Can Ctr; IDS Pharm has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USC/Norris Can Ctr; IDS Pharm?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.